0.6928
Dariohealth Corp stock is traded at $0.6928, with a volume of 85,257.
It is up +0.41% in the last 24 hours and down -1.21% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$0.69
Open:
$0.69
24h Volume:
85,257
Relative Volume:
0.13
Market Cap:
$26.60M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-0.6726
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
-1.01%
1M Performance:
-1.21%
6M Performance:
-25.47%
1Y Performance:
-65.87%
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DRIO
Dariohealth Corp
|
0.6928 | 26.60M | 20.35M | -59.43M | -30.96M | -1.03 |
![]()
VEEV
Veeva Systems Inc
|
226.11 | 36.71B | 2.66B | 665.91M | 1.08B | 4.05 |
![]()
DOCS
Doximity Inc
|
72.51 | 13.61B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
SOLV
Solventum Corp
|
76.28 | 13.18B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
TEM
Tempus Ai Inc
|
69.57 | 10.95B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
109.43 | 9.48B | 1.15B | 96.70M | -161.99M | 1.09 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
Apr-22-21 | Initiated | Cowen | Outperform |
Mar-23-21 | Initiated | Stifel | Buy |
Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
Aug-17-20 | Initiated | Aegis Capital | Buy |
Aug-29-17 | Initiated | Aegis Capital | Buy |
May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth (NASDAQ:DRIO) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
DarioHealth Corp Inc. (DRIO) Price Performance: The Role of Volume and Liquidity - The InvestChronicle
DarioHealth Corp (DRIO)’s stock price range in the last year - US Post News
DarioHealth adds new Blue Cross Blue Shield to payer network - MSN
DarioHealth Corp (DRIO) rating downgrades by TD Cowen - Knox Daily
DarioHealth stock hits 52-week low at $0.63 amid market challenges - MSN
DarioHealth Corp. (DRIO) Expands Health Plan Reach with New Blue Cross Blue Shield Agreement - Yahoo Finance
How does DRIO’s price to cash per share ratio compare in the market? - US Post News
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market - sharewise
DarioHealth Gains on Deal with Blue Cross - Baystreet.ca
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market | FinancialContent Business Page - Financial Content
DarioHealth inks deal with Blue Cross Blue Shield By Investing.com - Investing.com Nigeria
DarioHealth inks deal with Blue Cross Blue Shield - MSN
DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base - Financial Times
Comparing DarioHealth (NASDAQ:DRIO) and PROCEPT BioRobotics (NASDAQ:PRCT) - Defense World
DarioHealth (NASDAQ:DRIO) Stock Rating Lowered by TD Cowen - Defense World
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation - Business Wire
Digital Health Pioneer DarioHealth Crushes Revenue Targets with Fortune 500 Partnerships - StockTitan
TD Cowen cuts DarioHealth stock rating amid growth concerns - MSN
TD Cowen Downgrades DarioHealth to Hold From Buy, Adjusts Price Target to $1 From $2 - Marketscreener.com
DarioHealth Corp. Secures $25.6 Million Private Placement to Support Strategic Operational Objectives - Defense World
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy - MSN
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 - PR Newswire
DarioHealth Secures $25.6M Funding, Extends Cash Runway Through Q3 2024 - StockTitan
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
DarioHealth Corp (DRIO): AI Solutions for Health and Wellness - Insider Monkey
DRIODarioHealth Corp. Latest Stock News & Market Updates - StockTitan
DarioHealth Expands Weight Loss Platform With GLP-1 Prescriptions as Stock Surges 14% - StockTitan
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets - WV News
DarioHealth Partners With MediOrbis to Launch Comprehensive GLP-1 Weight Loss Program - StockTitan
DarioHealth Corp. announced that it expects to receive $6.824 million in funding -January 06, 2025 - Marketscreener.com
DarioHealth Corp. (NASDAQ:DRIO) Short Interest Update - Defense World
DarioHealth stock hits 52-week low at $0.64 amid market challenges - Investing.com
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges By Investing.com - Investing.com South Africa
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges - Investing.com Canada
DarioHealth Corp confirms new board, ratifies auditors - Investing.com India
DarioHealth Corp confirms new board, ratifies auditors By Investing.com - Investing.com UK
Dario Signs Four New Employer Contracts Across Full Product Suite - The Eastern Progress Online
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges - Investing.com Canada
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges By Investing.com - Investing.com South Africa
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):